Author

Jill F. Hallin

Mirati Therapeutics (United States)ORCID 0000-0002-8443-7116Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:imaging· 1 Organism:mouse· 1

Frequent Co-Authors

Eric M. GaleiD· 1 shared Ethan J. FrenchiD· 1 shared Farzad MoloudiiD· 1 shared Ian A. RamsayiD· 1 shared Ibrahim Ragab EissaiD· 1 shared Jonah Weigand‐WhittieriD· 1 shared Kenneth K. TanabeiD· 1 shared Manyu JiniD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Eric M. GaleORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyCancer ResearchPeer-reviewedSep 5, 2025

Molecular Magnetic Resonance Imaging of Dysregulated Zinc Secretion Detects Early Pancreatic Ductal Adenocarcinoma Lesions and Response to KRASG12D Inhibitor Treatment

Veronica Clavijo Jordan, Mozhdeh Sojoodi, Farzad Moloudi…·Peter D. Caravan

This study uses SSZS MRI to detect early PDAC lesions and monitor treatment response and recurrence.

2 citations

𝕏 PostBluesky